Inhibition by 6-mercaptopurine of the binding of a benzo(a)pyrene diol-epoxide to DNA in Chinese hamster ovary cells.
The finding that 7r,8t-dihydroxy-9,10-t-oxy-7,8,9,10-tetrahydrobenzo(a)pyrene (BPDE-I) is stabilized against hydrolysis by binding to cellular membranes suggested that nucleophilic compounds which would colocalize with BPDE-I in membranes might inhibit the deleterious biological effects of BPDE-I. We have explored the possibility that hydrophobic, sulfhydryl-containing compounds might provide such inhibition using the binding of BPDE-I to DNA in Chinese hamster ovary cells as a biological end point. Of several such compounds tested, 6-mercaptopurine (6-MP) was the most potent, exhibiting 50% inhibition of BPDE-I:DNA binding at about 30 microM and about 95% inhibition at 500 microM. 6-MP, at concentrations of 30 microM or greater, was also effective in preventing the induction of mutations by BPDE-I at the aprt locus. By varying the time of addition of the two compounds, it was shown that the action of 6-MP is intracellular. In vitro, 6-MP readily forms an adduct with BPDE-I, and the same adduct is found as a major metabolite in cells treated with BPDE-I and 6-MP. These findings are consistent with the hypothesis that 6-MP and BPDE-I colocalize in membranes of Chinese hamster ovary cells and form a covalent adduct, thus preventing the BPDE-I from interacting with critical cellular macromolecules such as DNA. Several nontoxic derivatives of 6-MP (9-methyl-6-MP, 2,6-dithiopurine) or analogues of 6-MP (4-mercapto-1H-pyrazolo[3,4-d]pyrimidine) were also tested in the Chinese hamster ovary cell system and found to inhibit binding of BPDE-I to DNA with potencies comparable to that of 6-MP.
MacLeod
M C
MC
Department of Experimental Carcinogenesis, Science Park-Research Division, University of Texas System Cancer Center, Smithville 78957.
Humphrey
R M
RM
Bickerstaff
T
T
Daylong
A
A
D015123:7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide / Q000378:metabolism* / Q000494:pharmacology; D000818:Animals; D002460:Cell Line; D002470:Cell Survival / Q000187:drug effects; D006224:Cricetinae; D003412:Cricetulus; D004247:DNA / Q000187:drug effects / Q000378:metabolism*; D018736:DNA Adducts; D004101:Dihydroxydihydrobenzopyrenes / Q000378:metabolism*; D005260:Female; D007700:Kinetics; D015122:Mercaptopurine / Q000494:pharmacology*; D009152:Mutagenicity Tests; D010053:Ovary
D018736:DNA Adducts; D004101:Dihydroxydihydrobenzopyrenes; C043931:benzo(a)pyrene-7,8-dihydrodiol-9,10-epoxide-DNA; D015123:7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide; D004247:DNA; D015122:Mercaptopurine